| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/11/2006 | EP1613621A1 Prostaglandin analogs as ep4 receptor agonists |
| 01/11/2006 | EP1613616A2 Process for making substituted pyrazoles |
| 01/11/2006 | EP1613594A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 01/11/2006 | EP1613593A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 01/11/2006 | EP1613592A2 Hydroxamic acid compounds and methods of use thereof |
| 01/11/2006 | EP1613591A1 Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof |
| 01/11/2006 | EP1613304A1 Dpp-iv inhibitors |
| 01/11/2006 | EP1370529B1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720228A Process for making risperidone and intermediates therefor |
| 01/11/2006 | CN1235879C Process for preparing room temperature ionic liquid |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984738 Reduction, catalytic hydrogenation |
| 01/10/2006 | US6984663 Cyclohexyl sulphones |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/05/2006 | WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals |
| 01/05/2006 | WO2006001751A1 Chemical compounds i |
| 01/05/2006 | WO2006001031A1 1-benzyl-4- ` (5,6-dimethoxy-1-indanone)-2-yl! methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
| 01/05/2006 | US20060004220 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004049 N-substituted piperidines and their use as pharrmaceuticals |
| 01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
| 01/05/2006 | US20060004004 Novel gamma secretase inhibitors |
| 01/05/2006 | US20060003988 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2006 | CA2584502A1 2-methylpropanamides and their use as pharmaceuticals |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/05/2006 | CA2571309A1 Chemical compounds |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/04/2006 | EP1612207A1 Processes and intermediates for preparing 2-substituted piperidine stereoisomers |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610786A1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1309557B1 Amlodipine hemimaleate |
| 01/04/2006 | EP1189886B1 Ethanesulfonyl-piperidine derivatives |
| 01/04/2006 | EP1173172B1 Synergistic effects of amlodipine and the hydroxylated metabolite of atorvastatin |
| 01/04/2006 | CN1717390A Piperazine and piperidine derivatives for treatment of neurological diseases |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
| 01/04/2006 | CN1715271A Method for extracting and preparing N-methyl-1-deoxy noijirimycin |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2235747C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123679A2 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123678A1 Cosmetic use of piperidine derivatives |
| 12/29/2005 | WO2005107374A3 A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative |
| 12/29/2005 | US20050288510 Beta-nucleating, light stabilizing agents for polypropylene |
| 12/29/2005 | US20050288435 Thermoplastic compositions with enhanced melt flow and compatibility |
| 12/29/2005 | US20050288338 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288330 Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) |
| 12/29/2005 | US20050288329 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor |
| 12/29/2005 | US20050288327 Small molecule inhibitors of HER2 expression |
| 12/29/2005 | US20050288317 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists |
| 12/29/2005 | US20050288281 Hetero isonipecotic modulators of vanilloid VR1 receptor |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | US20050288269 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 12/29/2005 | CA2570075A1 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/28/2005 | EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/28/2005 | EP1609788A1 Novel crystal of fluorobenzamide derivative |
| 12/28/2005 | EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 12/28/2005 | EP1608620A1 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 12/28/2005 | EP1608619A1 Muscarinic agonists |
| 12/28/2005 | EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 12/28/2005 | EP1608371A1 Process for the preparation of donepezil and derivatives thereof |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | EP1053238B1 Therapeutic compounds |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/27/2005 | US6979686 A piperidinyl-phenyl-pyridinyl-pyrazole derivatives; tumor necrosis factor mediated disorders, bone resorption, graft vs. host reaction, atherosclerosis, arthritis, rheumatoid arthritis, gout, psoriasis; chemical synthesis |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/27/2005 | CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 12/22/2005 | WO2005121157A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts |
| 12/22/2005 | WO2005121092A1 New substituted piperidines as modulators of dopamine neurotransmission |
| 12/22/2005 | WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 12/22/2005 | WO2005121090A1 Substituted piperidines that have antiangiogenic activity |
| 12/22/2005 | WO2005121089A1 Dpp-iv inhibitors |
| 12/22/2005 | WO2005121088A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 12/22/2005 | WO2005121087A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 12/22/2005 | WO2005121086A2 Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| 12/22/2005 | WO2005103041A9 Treatment of cns disorders using cns target modulators |
| 12/22/2005 | WO2005102999A3 Crystalline forms of fexofenadine hydrochloride and processes for their preparation |